{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prospective&page=19", "query": { "intervention": "Prospective", "page": 19 }, "page_size": 10 }, "pagination": { "page": 19, "page_size": 10, "total_count": 9246, "total_pages": 925, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prospective&page=20&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prospective&page=18&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T18:37:27.787Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01771146", "title": "Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreas Cancer", "Localized Pancreas Cancer", "Non-metastatic Pancreas Cancer" ], "interventions": [ { "name": "FOLFIRINOX Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2012-10", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2017-01-31", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01771146" }, { "nct_id": "NCT06745388", "title": "Magnesium and Cramping", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Uterine Cramps", "Postoperative Pain Management", "Hysteroscopy" ], "interventions": [ { "name": "Magnesium sulfate", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corewell Health East", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 150, "start_date": "2025-07-29", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2025-08-20", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Royal Oak, Michigan", "locations": [ { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06745388" }, { "nct_id": "NCT02958566", "title": "Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colon Cancer", "Colon Diverticulosis", "Colonic Neoplasms", "Colonic Diverticulitis", "Pain, Postoperative", "Ileus", "Ileus Paralytic", "Ileus; Mechanical", "Constipation Drug Induced", "Constipation", "Rectum Cancer", "Rectum Neoplasm" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Orphenadrine", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Marcaine", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Methadone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Morphine Sulfate", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Dilaudid", "type": "DRUG" }, { "name": "Hydrocodone-Acetaminophen Tab 5-325 MG", "type": "DRUG" }, { "name": "HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Illinois College of Medicine at Peoria", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2017-01", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Peoria, Illinois", "locations": [ { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02958566" }, { "nct_id": "NCT01210651", "title": "Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression, Unipolar" ], "interventions": [ { "name": "Hatha Yoga Practice Group", "type": "BEHAVIORAL" }, { "name": "Attention Control Education Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 38, "start_date": "2010-05", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01210651" }, { "nct_id": "NCT06635629", "title": "Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cushing Syndrome" ], "interventions": [ { "name": "Desmopressin", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 140, "start_date": "2024-12-12", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06635629" }, { "nct_id": "NCT05790408", "title": "Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glaucoma", "Glaucoma Following Surgery" ], "interventions": [ { "name": "Digital microscope integrated with intraoperative OCT (Zeiss Artevo 800, Carl Zeiss Meditec AG)", "type": "DEVICE" }, { "name": "Spectralis Anterior-segment OCT (AS-OCT) (Heidelberg Engineering)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2020-08-18", "completion_date": "2022-01-12", "has_results": true, "last_update_posted_date": "2023-11-15", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05790408" }, { "nct_id": "NCT07665268", "title": "Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Skin Ulcer", "Pressure Ulcer (PU)", "Pressure Ulcer of Skin", "Pressure Sore", "Chronic Ulcer", "Pressure Wound" ], "interventions": [ { "name": "Activate™ Matrix + SOC", "type": "OTHER" }, { "name": "AmnioDefend™ FT Matrix + SOC", "type": "OTHER" }, { "name": "Palisade™ DM Matrix + SOC", "type": "OTHER" }, { "name": "Sentry™ SL Matrix + SOC", "type": "OTHER" }, { "name": "Shelter™ DM Matrix + SOC", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Sequence LifeScience, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2026-01-28", "completion_date": "2028-01-28", "has_results": false, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "North Royalton, Ohio", "locations": [ { "city": "North Royalton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07665268" }, { "nct_id": "NCT06660368", "title": "BCL2i CLAG-M in R/R Acute Myeloid Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsed or Refractory Acute Myeloid Leukemia (AML)" ], "interventions": [ { "name": "Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 52, "start_date": "2024-11-26", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 2, "location_summary": "Tampa, Florida • Boston, Massachusetts", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06660368" }, { "nct_id": "NCT04894110", "title": "Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Corneal Edema", "Corneal Endothelial Dysfunction", "Corneal Endothelial Dystrophy", "Fuchs Dystrophy", "Fuchs Endothelial Corneal Dystrophy", "Pseudophakic Bullous Keratopathy", "Bullous Keratopathy", "Endothelial Dysfunction", "Moderate Corneal Endothelial Decompensation" ], "interventions": [ { "name": "EO2002", "type": "BIOLOGICAL" }, { "name": "EO2002 low dose", "type": "BIOLOGICAL" }, { "name": "EO2002 mid dose", "type": "BIOLOGICAL" }, { "name": "EO2002 high dose", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emmecell", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 42, "start_date": "2021-06-22", "completion_date": "2024-10-03", "has_results": false, "last_update_posted_date": "2025-03-05", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 8, "location_summary": "Greater Los Angeles, California • San Diego, California • Miami, Florida + 5 more", "locations": [ { "city": "Greater Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Palm Beach Gardens", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04894110" }, { "nct_id": "NCT03680846", "title": "Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Back Pain" ], "interventions": [ { "name": "HF10 Therapy", "type": "DEVICE" }, { "name": "CMM", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Nevro Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 211, "start_date": "2018-09-05", "completion_date": "2022-05-09", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-10-25T18:37:27.787Z", "location_count": 1, "location_summary": "Redwood City, California", "locations": [ { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03680846" } ] }